Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread?
NCT01895920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-02-27
Summary
This project aims at characterizing HIV-1 viral biofilms structural and functional properties and at deciphering its role as a new viral reservoir and as a new mode of viral spread. The prospective national study will be conducted on cells isolated from blood samples from 20 patients infected with HIV.
Conditions
- HIV Infection
Interventions
- OTHER
-
Blood sample
Sponsors & Collaborators
-
ANRS, Emerging Infectious Diseases
lead OTHER_GOV
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2018-02-28
- Completion
- 2018-02-28
Countries
- France
Study Locations
More Related Trials
-
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
NCT05854381 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
NCT02591420 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
NCT00125099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers
NCT00122564 ·Status: TERMINATED ·Phase: PHASE1
-
Analysis of Immune Responses to HIV Vaccines
NCT00068978 ·Status: COMPLETED
-
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months
NCT00000749 ·Status: COMPLETED ·Phase: PHASE1
-
Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity
NCT02886416 ·Status: COMPLETED
-
The Role of Probiotics in HIV Patients With Immunological Non-Responder
NCT03568812 ·Status: COMPLETED ·Phase: PHASE2
-
Selection of a Protective T Cell-based HIV-1/FIV Vaccine
NCT02389595 ·Status: ACTIVE_NOT_RECRUITING
-
Primary Infection Cohort
NCT03148964 ·Status: UNKNOWN
-
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
NCT00000779 ·Status: COMPLETED ·Phase: PHASE1
-
Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.
NCT00148824 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study
NCT00002037 ·Status: COMPLETED ·Phase: NA
-
Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
NCT00789789 ·Status: TERMINATED
-
Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection
NCT00001763 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers
NCT00000832 ·Status: COMPLETED ·Phase: PHASE1
-
Probiotic Visbiome for Inflammation and Translocation in HIV Ι
NCT02441244 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells
NCT03856996 ·Status: COMPLETED ·Phase: PHASE1
-
Resistance to HIV Infection
NCT00069485 ·Status: UNKNOWN
-
Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients
NCT00002012 ·Status: COMPLETED ·Phase: NA
-
Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
NCT00955006 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
NCT00440206 ·Status: COMPLETED
-
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
NCT00000632 ·Status: COMPLETED ·Phase: PHASE1
-
Perturbing of HIV Reservoir With Immune Stimulation
NCT02707692 ·Status: COMPLETED ·Phase: NA
-
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals
NCT00001042 ·Status: COMPLETED ·Phase: PHASE1